Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019
ObjectiveTo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.MethodsIn 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smoke...
Saved in:
| Published in | Tobacco control Vol. 32; no. e2; pp. e145 - e152 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BMJ Publishing Group Ltd
01.08.2023
BMJ Publishing Group LTD BMJ Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0964-4563 1468-3318 1468-3318 |
| DOI | 10.1136/tobaccocontrol-2021-056901 |
Cover
| Abstract | ObjectiveTo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.MethodsIn 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).ResultsIn 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was −7.3% (95% CI −14.4 to –0.4) and for e-cigarettes versus any other method was −7.7% (95% CI −12.2 to –3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.ConclusionsSales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse. |
|---|---|
| AbstractList | To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.
In 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).
In 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was -7.3% (95% CI -14.4 to -0.4) and for e-cigarettes versus any other method was -7.7% (95% CI -12.2 to -3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.
Sales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse. ObjectiveTo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.MethodsIn 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).ResultsIn 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was −7.3% (95% CI −14.4 to –0.4) and for e-cigarettes versus any other method was −7.7% (95% CI −12.2 to –3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.ConclusionsSales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse. To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.OBJECTIVETo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.In 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).METHODSIn 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).In 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was -7.3% (95% CI -14.4 to -0.4) and for e-cigarettes versus any other method was -7.7% (95% CI -12.2 to -3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.RESULTSIn 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was -7.3% (95% CI -14.4 to -0.4) and for e-cigarettes versus any other method was -7.7% (95% CI -12.2 to -3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.Sales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse.CONCLUSIONSSales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse. |
| Author | Strong, David R Leas, Eric C Trinidad, Dennis R Benmarhnia, Tarik Messer, Karen Pierce, John P Chen, Ruifeng Stone, Matthew McMenamin, Sara B White, Martha M |
| AuthorAffiliation | 1 Herbert Wertheim School of Public Health and Human Longevity Science , University of California San Diego , La Jolla , California , USA 2 Moores Cancer Center , University of California San Diego , La Jolla , California , USA 3 Scripps Institution of Oceanography , University of California San Diego , La Jolla , California , USA |
| AuthorAffiliation_xml | – name: 1 Herbert Wertheim School of Public Health and Human Longevity Science , University of California San Diego , La Jolla , California , USA – name: 2 Moores Cancer Center , University of California San Diego , La Jolla , California , USA – name: 3 Scripps Institution of Oceanography , University of California San Diego , La Jolla , California , USA |
| Author_xml | – sequence: 1 givenname: Ruifeng surname: Chen fullname: Chen, Ruifeng organization: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA – sequence: 2 givenname: John P orcidid: 0000-0002-0075-7471 surname: Pierce fullname: Pierce, John P email: jppierce@ucsd.edu organization: Moores Cancer Center, University of California San Diego, La Jolla, California, USA – sequence: 3 givenname: Eric C surname: Leas fullname: Leas, Eric C organization: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA – sequence: 4 givenname: Tarik surname: Benmarhnia fullname: Benmarhnia, Tarik organization: Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, USA – sequence: 5 givenname: David R surname: Strong fullname: Strong, David R organization: Moores Cancer Center, University of California San Diego, La Jolla, California, USA – sequence: 6 givenname: Martha M surname: White fullname: White, Martha M organization: Moores Cancer Center, University of California San Diego, La Jolla, California, USA – sequence: 7 givenname: Matthew orcidid: 0000-0002-1152-0621 surname: Stone fullname: Stone, Matthew organization: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA – sequence: 8 givenname: Dennis R surname: Trinidad fullname: Trinidad, Dennis R organization: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA – sequence: 9 givenname: Sara B surname: McMenamin fullname: McMenamin, Sara B organization: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA – sequence: 10 givenname: Karen surname: Messer fullname: Messer, Karen organization: Moores Cancer Center, University of California San Diego, La Jolla, California, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35131948$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkcFu1DAQhi1URLeFV0AWXDg04LGdxOkFqqpQpEogUc6WYzu7XhK7tZ2VeuMd-oY8CS7bAu2pkqU5-Jt__pl_D-344C1Cr4C8BWDNuxx6pXXQwecYxooSChWpm47AE7QA3oiKMRA7aEG6hle8btgu2ktpTQiwtoZnaJfVwKDjYoGmk2GwOruN9TYlHAZsK-2WKtqcbcKqPGcSHkLEaQo_nF9iXUCVXfCH2G6csV5bPMQw4byy-OvR-Sn-lmdzhXVYhZgPMCXQ_vp5XUr3HD0d1Jjsi9u6j75_PDk_Pq3Ovnz6fHx0VvV1S3MFQosWRK9M2_Fi2VAwrO5haClnxlBjhlobZjmx3IBmlCkiegNcKNWD6dg-er_VvZj7yRpty6XUKC-im1S8kkE5ef_Hu5Vcho0EwimrKSkKb24VYricbcpycknbcVTehjlJ2tBGiK4TdUFfP0DXYY6-7CepYB0hNW95oV7-b-mvl7soCvBhC-gYUop2kNrlP3cuDt1YrMmb9OX99OVN-nKbfpE4fCBxN-VRzc22uZ_W_zZ4RONvv9bN7Q |
| CitedBy_id | crossref_primary_10_1136_tc_2023_058453 crossref_primary_10_18332_tid_163300 crossref_primary_10_18332_tpc_192694 crossref_primary_10_1111_add_16206 crossref_primary_10_1111_1753_6405_13248 crossref_primary_10_1016_j_ypmed_2022_107391 crossref_primary_10_1093_ntr_ntac227 crossref_primary_10_1056_EVIDoa2300229 crossref_primary_10_1038_s41406_024_1451_2 crossref_primary_10_1177_11782218221114971 crossref_primary_10_1016_j_ajpc_2022_100342 crossref_primary_10_1093_ntr_ntae074 crossref_primary_10_1080_09540121_2023_2180476 crossref_primary_10_1080_19424396_2025_2474830 crossref_primary_10_1016_j_ecoenv_2024_116002 crossref_primary_10_36660_abc_20240063 crossref_primary_10_1136_tc_2022_057772 crossref_primary_10_1136_tc_2023_058209 crossref_primary_10_1016_j_tox_2024_153964 crossref_primary_10_7759_cureus_74037 crossref_primary_10_3390_life13030827 crossref_primary_10_3389_fpubh_2022_1001036 crossref_primary_10_1016_j_ijcrp_2025_200375 crossref_primary_10_1055_a_2034_6214 crossref_primary_10_55544_jrasb_3_1_33 crossref_primary_10_1371_journal_pone_0303245 crossref_primary_10_1055_a_2243_9399 crossref_primary_10_1093_ntr_ntac241 crossref_primary_10_18332_tid_189396 crossref_primary_10_1016_j_etdah_2024_100160 crossref_primary_10_1093_ntr_ntac089 crossref_primary_10_18332_tid_156038 crossref_primary_10_3390_cells13161330 crossref_primary_10_1055_a_2194_5666 crossref_primary_10_1513_AnnalsATS_202209_796ST crossref_primary_10_1177_00469580231214457 crossref_primary_10_2196_42544 crossref_primary_10_1016_j_cptl_2024_102158 crossref_primary_10_7759_cureus_25330 crossref_primary_10_1186_s12931_023_02438_x crossref_primary_10_1002_jbt_70116 crossref_primary_10_4187_respcare_11042 crossref_primary_10_1111_add_16437 crossref_primary_10_3390_healthcare12141410 crossref_primary_10_1111_resp_14466 crossref_primary_10_1016_j_cjca_2022_08_001 crossref_primary_10_1021_acs_chemrestox_4c00520 crossref_primary_10_3390_ijerph19138120 crossref_primary_10_1097_MD_0000000000038708 crossref_primary_10_2196_49668 crossref_primary_10_1001_jamanetworkopen_2025_0089 crossref_primary_10_1007_s10935_022_00678_z crossref_primary_10_3390_ijms25158554 crossref_primary_10_2147_JMDH_S419945 crossref_primary_10_1016_j_genhosppsych_2025_02_013 |
| Cites_doi | 10.1016/j.drugalcdep.2019.05.029 10.1016/j.drugalcdep.2017.05.010 10.1007/s00213-020-05734-2 10.1093/ntr/ntaa182 10.1093/ntr/ntz114 10.1093/ntr/ntu174 10.1093/pan/mpl013 10.1093/aje/kwaa161 10.1093/ntr/ntv182 10.1136/tobaccocontrol-2016-052934 10.1371/journal.pone.0237938 10.1136/tobaccocontrol-2021-056483 10.1016/j.drugalcdep.2016.10.018 10.1093/ntr/ntaa234 10.1001/jama.2018.10488 10.1002/bimj.201700067 10.1136/tobaccocontrol-2018-054796 10.1136/tobaccocontrol-2020-055816 10.5888/pcd14.160600 10.1001/jamanetworkopen.2021.28810 10.1056/NEJMc1814130 10.1093/ntr/ntab001 10.1158/1055-9965.EPI-19-0013 10.1111/j.2517-6161.1996.tb02080.x 10.1002/14651858.CD010216.pub 10.1136/tobaccocontrol-2020-056367 10.1136/tobaccocontrol-2017-054108 10.1001/jama.2020.18967 10.3998/2027.42/162579 10.17226/24952 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
| DBID | 9YT ACMMV AAYXX CITATION NPM 3V. 7WY 7X2 7X7 7XB 883 88E 8FE 8FH 8FI 8FJ 8FK 8FL ABUWG AEUYN AFKRA ATCPS AZQEC BENPR BEZIV BHPHI BTHHO CCPQU DWQXO FRNLG FYUFA GHDGH HCIFZ K60 K6~ K9- K9. M0F M0K M0R M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQBIZ PQBZA PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/tobaccocontrol-2021-056901 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef PubMed ProQuest Central (Corporate) ABI/INFORM Collection Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Trade & Industry (Alumni) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials - QC ProQuest Central Business Premium Collection Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea Business Premium Collection (Alumni) Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Business Collection (Alumni Edition) ProQuest Business Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ABI/INFORM Trade & Industry Agricultural Science Database Consumer Health Database ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Agricultural Science Database ProQuest Business Collection (Alumni Edition) ProQuest One Business ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ABI/INFORM Complete ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Trade & Industry (Alumni Edition) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Business Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Business (Alumni) ABI/INFORM Trade & Industry ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Economics Social Welfare & Social Work |
| EISSN | 1468-3318 |
| EndPage | e152 |
| ExternalDocumentID | PMC10423520 35131948 10_1136_tobaccocontrol_2021_056901 tobaccocontrol |
| Genre | Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: Tobacco-Related Disease Research Program of the University of California, Office of the President – fundername: National Institutes of Health grantid: R01CA234539 funderid: http://dx.doi.org/10.13039/100000002 – fundername: ; – fundername: ; grantid: R01CA234539 |
| GroupedDBID | --- ..I .VT 0R~ 123 18M 29Q 2WC 39C 4.4 40O 53G 5RE 5VS 6PF 7WY 7X2 7X7 7~S 883 88E 8FE 8FH 8FI 8FJ 8FL 8R4 8R5 9YT AACGO AAHLL AAKAS AANCE AAOJX AAWJN AAWTL ABAAH ABBHK ABJNI ABKDF ABMQD ABPLY ABTFR ABTLG ABUWG ABVAJ ABXSQ ACGFO ACGFS ACGTL ACHIC ACHQT ACHTP ACMFJ ACMMV ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADFRT ADQXQ ADULT ADZCM AENEX AEUPB AEUYN AEXZC AFKRA AFRAH AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AQVQM ASPBG ATCPS AVWKF AZFZN AZQEC BAWUL BENPR BEZIV BHPHI BKNYI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C45 CCPQU CS3 CXRWF DCCCD DIK DU5 DWQXO E3Z EBS EJD EX3 F5P FEDTE FRNLG FYUFA H13 HAJ HCIFZ HMCUK HQ3 HTVGU HVGLF HYE HZ~ IAO IEA IHR INH INR IOF IPSME ITC J8S JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST K60 K6~ K9- KQ8 M0F M0K M0R M1P N9A NTWIH NXWIF O9- OK1 OVD P2P PCD PHGZT PQBIZ PQBZA PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 SA0 TEORI TR2 UAW UKHRP UYXKK V24 VM9 W8F WOW YFH YQY AAYXX ACQHZ AERUA CITATION PHGZM NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-b572t-18c8718bad794375d21d35b1f7243dd2ddf5cd3e40e4d1c323a08bd148aab1d93 |
| IEDL.DBID | 9YT |
| ISSN | 0964-4563 1468-3318 |
| IngestDate | Thu Aug 21 18:40:47 EDT 2025 Thu Sep 04 22:19:41 EDT 2025 Fri Jul 25 21:32:54 EDT 2025 Mon Jul 21 05:54:58 EDT 2025 Tue Jul 01 02:36:15 EDT 2025 Thu Apr 24 23:13:11 EDT 2025 Thu Apr 24 23:02:03 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | e2 |
| Keywords | electronic nicotine delivery devices Surveillance and monitoring addiction cessation |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b572t-18c8718bad794375d21d35b1f7243dd2ddf5cd3e40e4d1c323a08bd148aab1d93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0075-7471 0000-0002-1152-0621 |
| OpenAccessLink | https://tobaccocontrol.bmj.com/content/32/e2/e145.full |
| PMID | 35131948 |
| PQID | 2839005474 |
| PQPubID | 2041049 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10423520 proquest_miscellaneous_2626889985 proquest_journals_2839005474 pubmed_primary_35131948 crossref_citationtrail_10_1136_tobaccocontrol_2021_056901 crossref_primary_10_1136_tobaccocontrol_2021_056901 bmj_journals_10_1136_tobaccocontrol_2021_056901 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-08-01 |
| PublicationDateYYYYMMDD | 2023-08-01 |
| PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationTitle | Tobacco control |
| PublicationTitleAbbrev | Tob Control |
| PublicationTitleAlternate | Tob Control |
| PublicationYear | 2023 |
| Publisher | BMJ Publishing Group Ltd BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Caraballo, Shafer, Patel (R1) 2017; 14 Lopez, Hiler, Soule (R14) 2016; 18 Pierce, Chen, Kealey (R10) 2021; 4 Patterson, LaPolt, Miranda (R30) 2021; 30 Glasser, Vojjala, Cantrell (R20) 2021; 23 Tibshirani (R25) 1996; 58 Pierce, Benmarhnia, Chen (R9) 2020; 15 Talih, Balhas, Eissenberg (R16) 2015; 17 Heinze, Wallisch, Dunkler (R26) 2018; 60 Strong, Pearson, Ehlke (R24) 2017; 178 Berry, Reynolds, Collins (R19) 2019; 28 Phillips-Waller, Przulj, Smith (R29) 2021; 238 Jackler, Ramamurthi (R28) 2019; 28 Miech, Johnston, O'Malley (R4) 2019; 380 Motschman, Gass, Wray (R6) 2016; 169 Kalkhoran, Chang, Rigotti (R21) 2020; 22 Hartmann-Boyce, McRobbie, Lindson (R5) 2020; 10 Goldenson, Fearon, Buchhalter (R17) 2021; 23 Romberg, Miller Lo, Cuccia (R3) 2019; 203 Rigotti (R2) 2020; 324 Chen, Pierce, Leas (R8) 2020; 189 Soule, Bansal-Travers, Grana (R15) 2023; 32 Prochaska, Vogel, Benowitz (R11) 2022; 31 King, Gammon, Marynak (R12) 2018; 320 Pierce, Leas, Benmarhnia (R22) 2021; 23 Hyland, Ambrose, Conway (R7) 2017; 26 Rostron, Corey, Chang (R33) 2019; 28 Ho, Imai, King (R27) 2007; 15 2023071902151885000_32.e2.e145.7 2023071902151885000_32.e2.e145.21 2023071902151885000_32.e2.e145.3 Motschman (2023071902151885000_32.e2.e145.6) 2016; 169 Pierce (2023071902151885000_32.e2.e145.10) 2021; 4 2023071902151885000_32.e2.e145.1 2023071902151885000_32.e2.e145.28 2023071902151885000_32.e2.e145.27 2023071902151885000_32.e2.e145.23 Heinze (2023071902151885000_32.e2.e145.26) 2018; 60 Glasser (2023071902151885000_32.e2.e145.20) 2021; 23 Pierce (2023071902151885000_32.e2.e145.22) 2021; 23 2023071902151885000_32.e2.e145.9 Chen (2023071902151885000_32.e2.e145.8) 2020; 189 Tibshirani (2023071902151885000_32.e2.e145.25) 1996; 58 2023071902151885000_32.e2.e145.32 2023071902151885000_32.e2.e145.31 2023071902151885000_32.e2.e145.30 Goldenson (2023071902151885000_32.e2.e145.17) 2021; 23 2023071902151885000_32.e2.e145.18 Hartmann-Boyce (2023071902151885000_32.e2.e145.5) 2020; 10 2023071902151885000_32.e2.e145.16 2023071902151885000_32.e2.e145.15 2023071902151885000_32.e2.e145.14 2023071902151885000_32.e2.e145.13 2023071902151885000_32.e2.e145.12 2023071902151885000_32.e2.e145.11 2023071902151885000_32.e2.e145.33 Miech (2023071902151885000_32.e2.e145.4) 2019; 380 Strong (2023071902151885000_32.e2.e145.24) 2017; 178 Rigotti (2023071902151885000_32.e2.e145.2) 2020; 324 2023071902151885000_32.e2.e145.19 Phillips-Waller (2023071902151885000_32.e2.e145.29) 2021; 238 |
| References_xml | – volume: 203 start-page: 1 year: 2019 ident: R3 article-title: Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013-2018 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2019.05.029 – volume: 178 start-page: 257 year: 2017 ident: R24 article-title: Indicators of dependence for different types of tobacco product users: descriptive findings from wave 1 (2013–2014) of the Population Assessment of Tobacco and Health (PATH) Study publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.05.010 – volume: 238 start-page: 825 year: 2021 ident: R29 article-title: Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products publication-title: Psychopharmacology doi: 10.1007/s00213-020-05734-2 – volume: 23 start-page: 669 year: 2021 ident: R20 article-title: Patterns of e-cigarette use and subsequent cigarette smoking cessation over 2 years (2013/2014–2015/2016) in the Population Assessment of Tobacco and Health Study publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntaa182 – volume: 22 start-page: 728 year: 2020 ident: R21 article-title: Electronic cigarette use and cigarette abstinence over 2 years among U.S. smokers in the Population Assessment of Tobacco and Health Study publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntz114 – volume: 17 start-page: 150 year: 2015 ident: R16 article-title: Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntu174 – volume: 15 start-page: 199 year: 2007 ident: R27 article-title: Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference publication-title: Political Analysis doi: 10.1093/pan/mpl013 – volume: 189 start-page: 1529 year: 2020 ident: R8 article-title: Use of electronic cigarettes to aid long-term smoking cessation in the United States: prospective evidence from the PATH Cohort Study publication-title: Am J Epidemiol doi: 10.1093/aje/kwaa161 – volume: 18 start-page: 720 year: 2016 ident: R14 article-title: Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntv182 – volume: 26 start-page: 371 year: 2017 ident: R7 article-title: Design and methods of the Population Assessment of Tobacco and Health (PATH) Study publication-title: Tob Control doi: 10.1136/tobaccocontrol-2016-052934 – volume: 15 year: 2020 ident: R9 article-title: Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: the PATH Study 2013–16 publication-title: PLoS One doi: 10.1371/journal.pone.0237938 – volume: 32 start-page: 124 year: 2023 ident: R15 article-title: Electronic cigarette use intensity measurement challenges and regulatory implications publication-title: Tob Control doi: 10.1136/tobaccocontrol-2021-056483 – volume: 169 start-page: 180 year: 2016 ident: R6 article-title: Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: a systematic review on varenicline publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2016.10.018 – volume: 23 start-page: 876 year: 2021 ident: R22 article-title: E-Cigarettes and cessation: the introduction of substantial bias in analyses of PATH Study publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntaa234 – volume: 320 start-page: 1379 year: 2018 ident: R12 article-title: Electronic cigarette sales in the United States, 2013-2017 publication-title: JAMA doi: 10.1001/jama.2018.10488 – volume: 60 start-page: 431 year: 2018 ident: R26 article-title: Variable selection - a review and recommendations for the practicing statistician publication-title: Biom J doi: 10.1002/bimj.201700067 – volume: 28 start-page: 623 year: 2019 ident: R28 article-title: Nicotine arms race: JUUL and the high-nicotine product market publication-title: Tob Control doi: 10.1136/tobaccocontrol-2018-054796 – volume: 30 start-page: e37 year: 2021 ident: R30 article-title: Switching stories: user testimonials on juul.com continue to contradict JUUL's switch ≠ cessation narrative publication-title: Tob Control doi: 10.1136/tobaccocontrol-2020-055816 – volume: 14 year: 2017 ident: R1 article-title: Quit methods used by US adult cigarette smokers, 2014-2016 publication-title: Prev Chronic Dis doi: 10.5888/pcd14.160600 – volume: 4 year: 2021 ident: R10 article-title: Incidence of cigarette smoking relapse among individuals who switched to e-cigarettes or other tobacco products publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.28810 – volume: 380 start-page: 192 year: 2019 ident: R4 article-title: Adolescent vaping and nicotine use in 2017–2018: U.S. national estimates publication-title: N Engl J Med doi: 10.1056/NEJMc1814130 – volume: 23 start-page: 947 year: 2021 ident: R17 article-title: An open-label, randomized, controlled, crossover study to assess nicotine pharmacokinetics and subjective effects of the JUUL system with three nicotine concentrations relative to combustible cigarettes in adult smokers publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntab001 – volume: 28 start-page: 1443 year: 2019 ident: R33 article-title: Associations of cigarettes smoked per day with biomarkers of exposure among U.S. adult cigarette smokers in the Population Assessment of Tobacco and Health (PATH) Study wave 1 (2013–2014) publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-19-0013 – volume: 58 start-page: 267 year: 1996 ident: R25 article-title: Regression shrinkage and selection via the LASSO publication-title: J R Stat Soc Series B doi: 10.1111/j.2517-6161.1996.tb02080.x – volume: 10 start-page: CD010216 year: 2020 ident: R5 article-title: Electronic cigarettes for smoking cessation publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD010216.pub – volume: 31 start-page: e88 year: 2022 ident: R11 article-title: Nicotine delivery and cigarette equivalents from vaping a JUULpod publication-title: Tob Control doi: 10.1136/tobaccocontrol-2020-056367 – volume: 28 start-page: 42 year: 2019 ident: R19 article-title: E-Cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013–2015 publication-title: Tob Control doi: 10.1136/tobaccocontrol-2017-054108 – volume: 324 start-page: 1835 year: 2020 ident: R2 article-title: Randomized trials of e-cigarettes for smoking cessation publication-title: JAMA doi: 10.1001/jama.2020.18967 – volume: 380 start-page: 192 year: 2019 ident: 2023071902151885000_32.e2.e145.4 article-title: Adolescent vaping and nicotine use in 2017–2018: U.S. national estimates publication-title: N Engl J Med doi: 10.1056/NEJMc1814130 – volume: 23 start-page: 876 year: 2021 ident: 2023071902151885000_32.e2.e145.22 article-title: E-Cigarettes and cessation: the introduction of substantial bias in analyses of PATH Study publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntaa234 – ident: 2023071902151885000_32.e2.e145.16 doi: 10.1093/ntr/ntu174 – ident: 2023071902151885000_32.e2.e145.9 doi: 10.1371/journal.pone.0237938 – ident: 2023071902151885000_32.e2.e145.27 doi: 10.1093/pan/mpl013 – volume: 60 start-page: 431 year: 2018 ident: 2023071902151885000_32.e2.e145.26 article-title: Variable selection - a review and recommendations for the practicing statistician publication-title: Biom J doi: 10.1002/bimj.201700067 – volume: 324 start-page: 1835 year: 2020 ident: 2023071902151885000_32.e2.e145.2 article-title: Randomized trials of e-cigarettes for smoking cessation publication-title: JAMA doi: 10.1001/jama.2020.18967 – volume: 4 year: 2021 ident: 2023071902151885000_32.e2.e145.10 article-title: Incidence of cigarette smoking relapse among individuals who switched to e-cigarettes or other tobacco products publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.28810 – ident: 2023071902151885000_32.e2.e145.11 doi: 10.1136/tobaccocontrol-2020-056367 – ident: 2023071902151885000_32.e2.e145.33 doi: 10.1158/1055-9965.EPI-19-0013 – ident: 2023071902151885000_32.e2.e145.13 – volume: 189 start-page: 1529 year: 2020 ident: 2023071902151885000_32.e2.e145.8 article-title: Use of electronic cigarettes to aid long-term smoking cessation in the United States: prospective evidence from the PATH Cohort Study publication-title: Am J Epidemiol doi: 10.1093/aje/kwaa161 – ident: 2023071902151885000_32.e2.e145.14 doi: 10.1093/ntr/ntv182 – ident: 2023071902151885000_32.e2.e145.31 doi: 10.3998/2027.42/162579 – ident: 2023071902151885000_32.e2.e145.32 – volume: 58 start-page: 267 year: 1996 ident: 2023071902151885000_32.e2.e145.25 article-title: Regression shrinkage and selection via the LASSO publication-title: J R Stat Soc Series B doi: 10.1111/j.2517-6161.1996.tb02080.x – volume: 10 start-page: CD010216 year: 2020 ident: 2023071902151885000_32.e2.e145.5 article-title: Electronic cigarettes for smoking cessation publication-title: Cochrane Database Syst Rev – ident: 2023071902151885000_32.e2.e145.18 doi: 10.17226/24952 – ident: 2023071902151885000_32.e2.e145.15 doi: 10.1136/tobaccocontrol-2021-056483 – ident: 2023071902151885000_32.e2.e145.23 – volume: 23 start-page: 947 year: 2021 ident: 2023071902151885000_32.e2.e145.17 article-title: An open-label, randomized, controlled, crossover study to assess nicotine pharmacokinetics and subjective effects of the JUUL system with three nicotine concentrations relative to combustible cigarettes in adult smokers publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntab001 – volume: 23 start-page: 669 year: 2021 ident: 2023071902151885000_32.e2.e145.20 article-title: Patterns of e-cigarette use and subsequent cigarette smoking cessation over 2 years (2013/2014–2015/2016) in the Population Assessment of Tobacco and Health Study publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntaa182 – volume: 169 start-page: 180 year: 2016 ident: 2023071902151885000_32.e2.e145.6 article-title: Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: a systematic review on varenicline publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2016.10.018 – ident: 2023071902151885000_32.e2.e145.12 doi: 10.1001/jama.2018.10488 – ident: 2023071902151885000_32.e2.e145.21 doi: 10.1093/ntr/ntz114 – volume: 178 start-page: 257 year: 2017 ident: 2023071902151885000_32.e2.e145.24 article-title: Indicators of dependence for different types of tobacco product users: descriptive findings from wave 1 (2013–2014) of the Population Assessment of Tobacco and Health (PATH) Study publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.05.010 – ident: 2023071902151885000_32.e2.e145.28 doi: 10.1136/tobaccocontrol-2018-054796 – ident: 2023071902151885000_32.e2.e145.1 doi: 10.5888/pcd14.160600 – ident: 2023071902151885000_32.e2.e145.7 doi: 10.1136/tobaccocontrol-2016-052934 – ident: 2023071902151885000_32.e2.e145.19 doi: 10.1136/tobaccocontrol-2017-054108 – volume: 238 start-page: 825 year: 2021 ident: 2023071902151885000_32.e2.e145.29 article-title: Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products publication-title: Psychopharmacology doi: 10.1007/s00213-020-05734-2 – ident: 2023071902151885000_32.e2.e145.3 doi: 10.1016/j.drugalcdep.2019.05.029 – ident: 2023071902151885000_32.e2.e145.30 doi: 10.1136/tobaccocontrol-2020-055816 |
| SSID | ssj0013751 |
| Score | 2.597187 |
| Snippet | ObjectiveTo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette... To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales. In... To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e145 |
| SubjectTerms | Abstinence addiction Adults cessation Cigarette industry Cigarette smoking Cigarettes Drug addiction Effectiveness Electronic cigarettes electronic nicotine delivery devices Households Hypotheses Longitudinal studies Nicotine Original Research Response rates Sales Smoking Smoking cessation Statistical analysis Surveillance and monitoring Tobacco |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Li9RAEG50BfUiOr6io7QgngyTfqUTL7KIyyCseNjFuYV-BWfdSdbJ7MGb_8F_6C-xKunMOAqyEAgkadJJVVd_1V1VHyEvjQbML7lPGdceHBSWpzZkOnW1MDLzMncFJjgff8znp_LDQi3iglsXwypHm9gbat86XCOfwTRYIr7Q8u3FtxRZo3B3NVJoXCc3GCARpG7QC73bRdA9_SKgdJkCUBCx6CgT-QxHiwOTM8SDg65w8KoVsjPBJGNXZ_vT1D_Y8-8Qyj_mpKO75E4Ek_RwkP49ci00E3JrzDXuJuTmcdw6n5DpkIhLP4fz2qwDfUXHC-36632yGsoYR9tH25qG1C17DlwAo9TAsfQdBYhLu1WL6-sUEwx6ub6hIXKTUsxWoYAp6afDkznFIMXvFDl415vXFECA_vXjJ5zKB-T06P3Ju3kaqRhSqzTfpKxw4FkV1ngsKKeV58wLZVmtuRTec-9r5bwIMgvSMye4MFlhPfhaxljmS_GQHDRtEx4T6h0W8RNBldxIbW1RMhsMc7qWyouaJ2QG_7-KQ6mrei9F5NW-xCqUWDVILCHlKKvKxcrmSLBxfqW2Ytv2YqjvcaVW01Eldh3daWhCXmxvw2jFLRjThPYSngH_sUAXVyXk0aBB29cKxcAeyiIhxZ5ubR_ASuD7d5rll74iOMPoJsWzJ__v11NyGz5CDPGLU3KwWV-GZ4CpNvZ5P3B-A2WyIMk priority: 102 providerName: ProQuest |
| Title | Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019 |
| URI | https://tobaccocontrol.bmj.com/content/32/e2/e145.full https://www.ncbi.nlm.nih.gov/pubmed/35131948 https://www.proquest.com/docview/2839005474 https://www.proquest.com/docview/2626889985 https://pubmed.ncbi.nlm.nih.gov/PMC10423520 |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB41rVR6QRBeKSFaJMQJN9mX1-YWqlYRUqoKpRBO1tq7VgONUyXpgRv_gX_IL2HGj5SUS5FWWtnetS3P7O433plvAN5Yg5hfCRdwYRwaKDwMUj8wQZZLqwZOhVlEAc7js3B0oT5O9XQHwiYWhrQ4w6mg8tM-SuffqsAGomoq1n0p-h4LV_qIfk-3YI_4uMiVL_46ud09MGXaRUTnKkCAIGuyUS7DO_dHHRFoTWvKynQA-1Jz1EhKBdTCB2-vVP_Az7telH8tS6eP4GGNJ9mwUoDHsOOLNjxowo1Xbdgf17vnbehWsbjsi7_K7dKzt6w5sVh-fwLzism4nv7YImc-yGZlGlzEo8ximbkVQ5TLVvMF_WJnFGNQivY983V6UkYBKwxhJTsfTkaM_BR_MErDu1y_Y4gDzO-fv7CKn8LF6cnkeBTU2RiCVBuxDniUoXEVpdYRp5zRTnAndcpzI5R0TjiX68xJrwZeOZ5JIe0gSh2aW9am3MXyGewWi8K_AOYy4vGTXsfCKpOmUcxTb3lmcqWdzEUH-vj9k3o0rZLSUJFhsi28hISXVMLrQNzIKslqcnPKsXF1r75y0_e6ovi4V69uoxK3L4pYLSYQbFQHXm8u44ClXRhb-MUNtkETMiIrV3fgeaVBm8c2CtiBaEu3Ng2IDHz7SjG7LEnBOTk4aTE4_O9v9xIO8EhWXo1d2F0vb_wrRFrrtActMzW9cnD1YG94PB5_xvrDydn5pz_y0Cnq |
| linkProvider | BMJ Publishing Group Ltd |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dahNBFB5KCtYb0fiXGnUE9colmb_MRihStSW1TSiSYu-2MzuzGNtka5IivfMdfB8fxifxnN3ZxChIbwqBhewOO8n5me_MnPMdQp4bDZhfchcxrh0EKKwTWd_WUZoJI9tOdtIYC5z7g07vSH44Vsdr5GdVC4NplZVPLBy1y1PcI2_BMthFfKHlm_OvEXaNwtPVqoWGCa0V3FZBMRYKO_b95TcI4WZbe-9B3i84390ZvutFoctAZJXm84jFKQQNsTUOudK0cpw5oSzLNJfCOe5cplInvGx76VgquDDt2DoII4yxzCEZEywB6xI3UGpk_e3O4PDj8hxDFw0gIU6QEUAVEWhPmei00F5h1iEjHbSVQ1yvsD8ULHN2_GV1ofwH_f6dxPnHqrh7m9wKcJZul_p3h6z5SZ1sVNXOszq50Q-H93XSLEuB6Sd_lpmppy9p9UU-Pb1LxiWRcvC-NM-oj9JR0YUX4DA18Bm5GQWQTWfjHHf4KZY4FJr1mvrQHZVivQwFVEsPt4c9immSlxS7AE_nryjAEP3r-w-4dO-Ro2sR031Sm-QT_5BQlyKNoPCqy43U1sZdZr1hqc6kciLjDdKC_z8JxjxLijhJdJJViSUosaSUWIN0K1klaeBWxxYfZ1caKxZjz0uGkSuNalYqsZzo0kYa5NniNvgLPAQyE59fwDMQwcYYZKsGeVBq0OK1QjHwyDJukHhFtxYPIBf56p3J6HPBSc4wv0rx9ub_5_WUbPSG_YPkYG-w_4jchB8kymzKJqnNpxf-MSC8uX0SzIiSk-u23N81rGSl |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF1VRSq8IAi3QIBFAp6w4r1lHSSEKkqUUlr1oRV5M3uzCDR2iVOhvvEP_A2fw5cw40tCQEJ9qWTJku2VL3PZM96ZOYQ8NRowv-Q-Ylx7CFDYILIh1pHLhJGxlwOXYIHz_sFgfCzfTdRkg_xsa2EwrbL1iZWj9oXDf-R9mAaHiC-07GdNWsThzuj16dcIGaRwpbWl06hVZC-cf4PwrXy1uwOyfsb56O3Rm3HUMAxEVmm-iFjiIGBIrPHYJ00rz5kXyrJMcym8595nynkRZBykZ05wYeLEegghjLHMYyMmcP9XtJASaSP0RK9WMHRF_QgRgowApIim4SkTgz5aqgN3V-eig55yiOgVMkPBBGdnn9enyH9w79_pm3_Mh6Mb5HoDZOl2rXk3yUbIO-RqW-dcdsjWfrNs3yG9ugiYfggnmZkH-py2B4r5l1tkVrdQbvwuLTIaIjet-HcBCFMD29SXFOA1LWcF_tunWNxQ6dRLGhpeVIqVMhTwLD3cPhpTTJA8p8j_O1-8oABA9K_vP2A3vE2OL0VId8hmXuThHqHeYQNBEdSQG6mtTYbMBsOczqTyIuNd0ofvnzZmXKZVhCQG6brEUpRYWkusS4atrFLXdFVHco-TC40Vy7GndW-RC43qtSqxetCVdXTJk-Vp8BS4_GPyUJzBNRC7Jhheqy65W2vQ8rZCMfDFMumSZE23lhdgF_L1M_n0U9WNnGFmleLx_f8_12OyBfaavt892HtArsH7iDqNskc2F_Oz8BCg3cI-qmyIko-XbbS_AYAPYkE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effectiveness+of+e-cigarettes+as+aids+for+smoking+cessation%3A+evidence+from+the+PATH+Study+cohort%2C+2017%E2%80%932019&rft.jtitle=Tobacco+control&rft.au=Chen%2C+Ruifeng&rft.au=Pierce%2C+John+P&rft.au=Leas%2C+Eric+C&rft.au=Benmarhnia%2C+Tarik&rft.date=2023-08-01&rft.issn=0964-4563&rft.eissn=1468-3318&rft.volume=32&rft.issue=e2&rft.spage=e145&rft.epage=e152&rft_id=info:doi/10.1136%2Ftobaccocontrol-2021-056901&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_tobaccocontrol_2021_056901 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0964-4563&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0964-4563&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0964-4563&client=summon |